Skip to main content
. 2016 Feb 16;34(11):1270–1277. doi: 10.1200/JCO.2015.65.0739

Fig 2.

Fig 2.

Ratio of the cumulative hazard for cancer mortality to all-cause mortality [ω(ΛCSMACM)] as a function of the normalized generalized competing event risk score versus normalized cancer mortality risk score versus normalized all-cause mortality risk score for (A-C) prostate cancer, (D-F) head and neck cancer, and (G-I) breast cancer. ω is calculated at 10 years for prostate cancer and 5 years for head and neck and breast cancer.